This is a single-arm, single center, phase II trial to investigate the feasibility and toxicity of tomotherapy for leptomeningeal metastases, which are defined as leptomeningeal metastases with or without brain metatstases.
This clinical trial was designed to investigate the efficiency and toxicity of tomotherapy for leptomeningeal metastases.